Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4B |
| 2 |
TC Energy
TRP
|
+$1.99B |
| 3 |
Amazon
AMZN
|
+$1.97B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.83B |
| 5 |
NVIDIA
NVDA
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.57B |
| 2 |
Scotiabank
BNS
|
+$1.51B |
| 3 |
Enbridge
ENB
|
+$1.47B |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.02B |
| 5 |
Medtronic
MDT
|
+$871M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 9.2% |
| 3 | Consumer Discretionary | 8.28% |
| 4 | Communication Services | 6.4% |
| 5 | Healthcare | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
First Trust Multi Cap Growth AlphaDEX Fund
FAD
$594M
| $8.03M | ﹤0.01% |
50,000
-1,870
| -4% | -$286K |
|
3177
Ecopetrol
EC
$34.5B
| $8.02M | ﹤0.01% |
871,025
+258,967
| +42% | +$2.32M |
|
3178
Blend Labs
BLND
$386M
| $8.02M | ﹤0.01% |
2,196,982
+1,368,965
| +165% | +$4.91M |
|
3179
JPMorgan Active Bond ETF
JBND
$8.52B
| $8.01M | ﹤0.01% |
+147,818
| New | +$7.93M |
|
3180
Enerpac Tool Group
EPAC
$1.93B
| $8M | ﹤0.01% |
195,122
+20,762
| +12% | +$838K |
|
|
AVDL
3181
DELISTED
Avadel Pharmaceuticals
AVDL
| $7.99M | ﹤0.01% |
523,072
+101,788
| +24% | +$1.32M |
|
3182
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$603M
| $7.99M | ﹤0.01% |
85,311
+35,237
| +70% | +$2.49M |
|
3183
Arlo Technologies
ARLO
$1.65B
| $7.97M | ﹤0.01% |
470,221
-1,128,210
| -71% | -$19.2M |
|
3184
ArriVent BioPharma
AVBP
$1.44B
| $7.97M | ﹤0.01% |
431,939
+92,743
| +27% | +$1.82M |
|
3185
Xtrackers S&P 500 ESG ETF
SNPE
$2.75B
| $7.95M | ﹤0.01% |
132,510
-8,984
| -6% | -$517K |
|
3186
Xerox
XRX
$425M
| $7.95M | ﹤0.01% |
2,115,531
+1,237,674
| +141% | +$5.47M |
|
|
SEMR
3187
DELISTED
Semrush
SEMR
| $7.95M | ﹤0.01% |
1,122,344
-134,197
| -11% | -$1.09M |
|
|
BBNX
3188
Beta Bionics
BBNX
$715M
| $7.93M | ﹤0.01% |
399,253
+88,252
| +28% | +$1.55M |
|
3189
Atlas Energy Solutions
AESI
$1.41B
| $7.91M | ﹤0.01% |
695,823
+46,782
| +7% | +$573K |
|
|
SCEC
3190
Sterling Capital Enhanced Core Bond ETF
SCEC
$602M
| $7.91M | ﹤0.01% |
+310,284
| New | +$7.84M |
|
3191
iShares US Regional Banks ETF
IAT
$681M
| $7.89M | ﹤0.01% |
150,111
-9,454
| -6% | -$493K |
|
3192
HUB Group
HUBG
$2.92B
| $7.87M | ﹤0.01% |
228,553
-21,501
| -9% | -$768K |
|
3193
Olema Pharmaceuticals
OLMA
$1.05B
| $7.87M | ﹤0.01% |
803,881
+79,299
| +11% | +$476K |
|
3194
Caleres
CAL
$487M
| $7.87M | ﹤0.01% |
603,438
+301,122
| +100% | +$4.36M |
|
|
BEAG
3195
Bold Eagle Acquisition Corp
BEAG
$335M
| $7.87M | ﹤0.01% |
756,618
| – | – |
|
3196
Sturm, Ruger & Co
RGR
$593M
| $7.87M | ﹤0.01% |
180,938
+15,859
| +10% | +$572K |
|
3197
CALL
Marriott International
MAR
$92.3B
| $7.87M | ﹤0.01% |
30,200
| – | – |
|
3198
Castle Biosciences
CSTL
$979M
| $7.86M | ﹤0.01% |
345,099
+71,656
| +26% | +$1.46M |
|
3199
CALL
Cencora
COR
$61.2B
| $7.84M | ﹤0.01% |
25,100
| – | – |
|
3200
Tennant Co
TNC
$1.26B
| $7.84M | ﹤0.01% |
96,684
+12,801
| +15% | +$1.05M |
|
Similar funds
Goldman Sachs's Q3 2025 Portfolio in Review
As of Q3 2025, Goldman Sachs held 6,765 positions worth $817B, up 11% from $736B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Goldman Sachs's Q3 2025 filing shows 707 new, 2,950 increased, 2,106 reduced and 470 closed positions. Its largest new stake was Fidelity Enhanced International ETF: 1,911,687 shares worth $67.4M. The largest sale was iShares Russell 2000 ETF, an estimated $1.57B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q3 2025 buy was Fidelity Enhanced International ETF: 1,911,687 shares worth $67.4M.
- Goldman Sachs added most to Microsoft in Q3 2025, an estimated $4B increase.
- Goldman Sachs's biggest Q3 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $1.57B.
- Goldman Sachs fully exited Ansys in Q3 2025, selling an estimated $564M.
- Goldman Sachs's ten largest holdings make up 22% of its $817B portfolio in Q3 2025.
- Goldman Sachs opened 707 new positions and closed 470 in Q3 2025.
- Goldman Sachs's portfolio value rose 11% quarter-over-quarter to $817B.
Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.